A Study Examining Adolescents With Non-Suicidal Self-Injury (RDoC)

March 22, 2024 updated by: University of Minnesota

A Longitudinal Study Examining Three RDoC Constructs in Adolescents With Non-Suicidal Self-Injury

This study will examine longitudinal brain development in young adolescent girls with a history of Non-Suicidal Self-Injury (NSSI). Specifically, three constructs outlined by the the Research Domains Criteria (RDoC) will be examined through self-assessment, MRI, and a cognitive battery.

Study Overview

Status

Active, not recruiting

Detailed Description

This study is designed to study brain development in 12-14 year old females with a history of NSSI. Assessments will take place over the course of three years, with three visits per year - a total of nine visits.

The first visit will take place at the Ambulatory Research Center (ARC) at the Fairview Riverside hospital complex. This visit will include a number of questionnaires designed to gather information about the participant's physical and psychological health. Additionally, measures of intelligence quotient (IQ) and demographics will be assessed.

The second visit will again take place at the ARC. For this visit, participants will be asked to partake in the Trier Social Stress Test (TSST) in which they prepare a short, five-minute speech and deliver the speech to an audience with an additional task to follow. The TSST will be videotaped. Following the completion of this task, the participant will complete computer tests in order to measure things like attention and memory. During the second visit, five saliva samples will be collected to measure levels of the hormone Cortisol. The participant will need to collect additional saliva samples at home.

The third visit will take place at the University of Minnesota Center for Magnetic Resonance Research (CMRR) and will involve a brain MRI. Before the MRI the participant will be asked to provide a urine sample and complete a drug and pregnancy test. During the MRI, the participant will be asked to lie quietly in the scanner. The participant will do activities such as resting, listening to music, and playing games using a button box while in the scanner.

The participant will need to come in to complete these assessments twice more at one and two years following the completion of the first set of visits - a total of nine visits overall.

Study Type

Observational

Enrollment (Actual)

168

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Minnesota
      • Minneapolis, Minnesota, United States, 55455
        • University of Minnesota
      • Minneapolis, Minnesota, United States, 55454
        • Ambulatory Research Center (ARC)
      • Minneapolis, Minnesota, United States, 55455
        • Center for Magnetic Resonance Research

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

12 years to 16 years (Child)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Adolescents with a history of NSSI will be recruited from community outlets such as flyers, as well as through social media (e.g., Facebook and Pandora). Additionally, these adolescents will be recruited through local clinicians who treat adolescent mood disorders. Healthy controls will be recruited through community outlets and social media.

Description

Inclusion Criteria:

  • 12-16 years old
  • Female
  • Has had first menstruation
  • Willingness to have de-identified data shared with RDoC database

Inclusion Criteria - Adolescents with Non-Suicidal Self-Injury:

  • Any history of self harm

Inclusion Criteria - Healthy Controls:

  • No history of self harm

Exclusion Criteria:

  • Male
  • Pregnancy
  • MRI Incompatibility
  • IQ of less than 80
  • Major Medical Illness
  • Diagnosis of any of the following: Primary Psychotic Disorder, Bipolar Spectrum Disorder, Autism Spectrum Disorder, Current or Past Substance Use Disorder

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Adolescents with NSSI
12-16 year old females who have a history of non-suicidal self-injury are included in this cohort. No interventions will be administered.
Healthy Controls
12-16 year old females with no history of non-suicidal self-injury are included in this cohort.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Self-Injurious Thoughts and Behaviors Interview (SITBI)
Time Frame: Baseline; 12 months; 24 months
This scale will be used to assess NSSI frequency in the past month, past year, and lifetime; average age of onset; severity of injuries (number of injuries per episode, severity of tissue damage -- worst point and average), function (automatic versus social, negative versus positive) and other information.
Baseline; 12 months; 24 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Saliva Cortisol Levels
Time Frame: Baseline; 12 months; 24 months
As a measure of stress response, cortisol levels will be measured after administration of the Trier Social Stress Test. This test is designed to measure HPA axis functioning in the context of an interpersonal threat. Intra- and inter-assay coefficients of variability will be calculated. Summary indexes including slope and area under the curve estimates of cortisol in response to threat and resting conditions will be used in subsequent analyses.
Baseline; 12 months; 24 months
Change in Beck Scale for Suicidal Ideation (BSSI)
Time Frame: Baseline; 12 months; 24 months
A 19-item interview, assesses current suicidal ideation, with ratings for active suicidal desire, specific suicide plans, and passive suicidal desire. If the adolescent is assessed to be at risk, a member of the research team will work with the family and the adolescent to develop a safety plan.
Baseline; 12 months; 24 months
Change in Inventory of Depression and Anxiety Symptoms (IDAS)
Time Frame: Baseline; 12 months; 24 months
The IDAS is a 54-item assessment that provides a score for 11 domains; we will focus on general depression, suicidality, traumatic intrusion, panic, and social anxiety.
Baseline; 12 months; 24 months
Change in Rejection Sensitivity Questionnaire
Time Frame: Baseline; 12 months; 24 months
This assessment measures predicted interpersonal sensitivity and difficulties.
Baseline; 12 months; 24 months
Change in Personality Assessment Inventory, Adolescent Form (PAI-A)
Time Frame: Baseline; 12 months; 24 months
A self-report personality indicator for adolescent populations based on 22 scales of psychological well-being.
Baseline; 12 months; 24 months
Change in the Dot-Probe Task
Time Frame: Baseline; 12 months; 24 months
A computerized assessment designed to assess attentional bias to threat, as well as provide a behavioral measure of "vigilance" to threat (reaction times for a spatial task influenced by the presence of emotion faces).
Baseline; 12 months; 24 months
Change in Self Perception Profile for Adolescents
Time Frame: Baseline; 12 months; 24 months
An assessment designed to evaluate and measure six self-concept domains: Scholastic Competence, Athletic Competence, Social Competence, Physical Appearance, and Behavioral Conduct and Global Self-Worth.
Baseline; 12 months; 24 months
Change in Barratt Impulsiveness Scale (BIS)
Time Frame: Baseline; 12 months; 24 months
This scale utilizes self-report measures of impulsiveness. It includes 30 items that are scored to yield six first-order factors (attention, motor, self-control, cognitive complexity, perseverance, and cognitive instability impulsiveness) and three second-order factors (attentional, motor, and non-planning impulsiveness).
Baseline; 12 months; 24 months
Change in UPPS-P
Time Frame: Baseline; 12 months; 24 months
This measure will be used to determine "Negative Urgency", or the tendency of an individual to act impulsively while they are in a state of negative affect.
Baseline; 12 months; 24 months
Change in the Emotional Go/NoGo task
Time Frame: Baseline; 12 months; 24 months
This measure will be used to assess response inhibition in the context of negative emotion contexts.
Baseline; 12 months; 24 months
Change in MRI Data
Time Frame: Baseline; 12 months; 24 months
Cortical thickness, brain activation, and functional connectivity several key networks (fronto-striatal, fronto-limbic, and medial cortical network) will be measured using structural and functional MRI.
Baseline; 12 months; 24 months
Change in Timeline Followback Method (TLFB) for NSSI
Time Frame: Baseline; 12 months; 24 months
A calendar format measure to retrospectively collect behavioral data that was adapted from an instrument for alcohol use will be used measure NSSI episodes that had occurred in the year between each visit.
Baseline; 12 months; 24 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Kathryn Cullen, University of Minnesota

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2016

Primary Completion (Actual)

July 18, 2022

Study Completion (Estimated)

July 18, 2025

Study Registration Dates

First Submitted

October 17, 2016

First Submitted That Met QC Criteria

October 26, 2016

First Posted (Estimated)

October 27, 2016

Study Record Updates

Last Update Posted (Actual)

March 25, 2024

Last Update Submitted That Met QC Criteria

March 22, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • PSYCH-2016-24795
  • 1R01MH107394-01A1 (U.S. NIH Grant/Contract)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Self-Injurious Behavior

3
Subscribe